Men’s Health Network debuts “My Cancer, My Plan” Podcast to help men navigate diagnosis, treatment decisions, and ...

Pfizer Inc. (NYSE:PFE) is among the Best Affordable Stocks Under $40 to Buy. On February 17, Pfizer Inc. (NYSE:PFE) announced positive results from its key BREAKWATER trial, which is testing BRAFTOVI ...

ZERO Prostate Cancer announces the 2026 ZERO Prostate Cancer Advocacy Summit will take place in person at the Hilton ...

In February of last year, Icon said it would “vigorously” defend a US lawsuit that stated company insiders had “motive and ...

A challenging public health policy landscape under health secretary Robert F. Kennedy has vaccine makers rethinking ...

By Stine Jacobsen and Louise Rasmussen COPENHAGEN, Feb 20 (Reuters) - Novo Nordisk will nominate drug industry veterans Jan van de Winkel and Ramona Sequeira to its board of directors, the company ...

After an FDA rejection of its spinocerebellar ataxia (SCA) therapy, Biohaven was forced to rethink its strategy—cutting R&D spend by 60% and channeling the spirit of a scrappy startup again as it ...

After the weight-loss drug boom, and with generics closing in, Big Pharma are gearing up for the next game-changer.

In the case of Covid19, the events in February 2020 in Milan and Cortina d'Ampezzo – the jewel of the Italian Alps – were the origins of the pandemic. Without their role, Covid19 might have been a ...

Report by Irish Fiscal Advisory Council highlights ‘exceptionally concentrated’ nature of Ireland’s corporate tax base ...

Danaher Corp. entered into a definitive agreement to acquire Masimo in an all-cash transaction valued at approximately $9.9 billion. Madrigal Pharmaceuticals signed an exclusive global license ...

Madrigal shares fell 11% despite again topping consensus sales numbers. Elsewhere, Daiichi Sankyo named a new research chief ...